Georgios Panagiotidis

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LEUKEMIA & LYMPHOMA. 2022;63(6):1387-1397

Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia.

Melén CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlén H-R; Christensson B; Sander B; Wahlin BE
Article: CLINICAL TOXICOLOGY. 2019;57(4):271-281

Potential pharmacobezoar formation of large size extended-release tablets and their dissolution - an in vitro study.

Hoegberg LCG; Refsgaard F; Pedersen SH; Personne M; Ullah S; Panagiotidis G; Petersen TS; Annas A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2016;60(7):4244-4251

Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota.

Rashid M-U; Rosenborg S; Panagiotidis G; Holm J; Söderberg Löfdal K; Weintraub A; Nord CE
Article: INNOVATIONS IN EDUCATION AND TEACHING INTERNATIONAL. 2016;53(2):203-214

'It's all connected!' Nursing students' experiences of a new form of case seminar integrating medical and nursing science

Olsson PT; Weurlander M; Mattiasson A-C; Hede GW; Panagiotidis G; Broberger E; Hult H; Wernerson A
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2015;2(suppl_1):750

Ecological Effect of Ceftaroline/Avibactam on the Normal Human Intestinal Microbiota

Nord CE; Rashid M-U; Rosenborg S; Panagiotidis G; Löfdal KS; Weintraub A
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2015;21(8):767.e1-767.e4

Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle.

Dalhoff A; Rashid M-U; Kapsner T; Panagiotidis G; Weintraub A; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(8):4504-4509

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota.

Rashid M-U; Rosenborg S; Panagiotidis G; Söderberg-Löfdal K; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2015;46(1):60-65

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.

Rashid M-U; Rosenborg S; Panagiotidis G; Löfdal KS; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2014;44(2):125-130

Ecological impact of MCB3837 on the normal human microbiota.

Rashid M-U; Dalhoff A; Bäckström T; Björkhem-Bergman L; Panagiotidis G; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2013;41(4):352-357

Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora.

Rashid M-U; Panagiotidis G; Bäckström T; Weintraub A; Nord CE
Article: ACTA NEUROLOGICA SCANDINAVICA. 2013;127(2):124-132

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers.

Nyholm D; Ehrnebo M; Lewander T; Trolin CG; Bäckström T; Panagiotidis G; Spira J; Nyström C; Aquilonius S-M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2012;68(9):1281-1286

The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans.

Helldén A; Panagiotidis G; Johansson P; Waters N; Waters S; Tedroff J; Bertilsson L
Article: JOURNAL OF NEUROIMAGING. 2012;22(1):28-32

A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry.

Comley RA; Cervenka S; Palhagen SE; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L; Nichols TE; Whitcher BJ
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2011;108(4):224-233

The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm.

Gustafsson LL; Wettermark B; Godman B; Andersén-Karlsson E; Bergman U; Hasselström J; Hensjö L-O; Hjemdahl P; Jägre I; Julander M; Ringertz B; Schmidt D; Sjöberg S; Sjöqvist F; Stiller C-O; Törnqvist E; Tryselius R; Vitols S; von Bahr C; Regional Drug Expert Consortium
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2010;36(6):537-541

Effect of ceftobiprole on the normal human intestinal microflora.

Bäckström T; Panagiotidis G; Beck O; Asker-Hagelberg C; Rashid M-U; Weintraub A; Nord CE
Article: BMC HEALTH SERVICES RESEARCH. 2010;10:128

Forecasting drug utilization and expenditure in a metropolitan health region.

Wettermark B; Persson ME; Wilking N; Kalin M; Korkmaz S; Hjemdahl P; Godman B; Petzold M; Gustafsson LL; Regional Drug Expert Consortium in Stockholm Count
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2010;54(5):1811-1814

Effect of ceftaroline on normal human intestinal microflora.

Panagiotidis G; Bäckström T; Asker-Hagelberg C; Jandourek A; Weintraub A; Nord CE
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2009;105(5):339-344

Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones.

Allmyr M; Panagiotidis G; Sparve E; Diczfalusy U; Sandborgh-Englund G
Article: THERAPEUTIC DRUG MONITORING. 2007;29(4):417-422

Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.

Panagiotidis G; Arthur HW; Lindh JD; Dahl M-L; Sjöqvist F
Article: BRAIN. 2006;129(Pt 8):2017-2028

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2005;14(7):493-499

Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.

Kimland E; Rane A; Ufer M; Panagiotidis G
Article: REGULATORY PEPTIDES. 2003;111(1-3):55-60

Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.

Akesson B; Panagiotidis G; Westermark P; Lundquist I
Article: BRITISH JOURNAL OF PHARMACOLOGY. 1996;119(4):758-764

Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

Akesson B; Mosén H; Panagiotidis G; Lundquist I
Article: ENDOCRINOLOGY. 1996;137(4):1219-1225

Islet acid glucan-1,4-alpha-glucosidase: a putative key enzyme in nutrient-stimulated insulin secretion.

Lundquist I; Panagiotidis G; Salehi A
Article: DIABETES. 1995;44(7):830-836

The pseudotetrasaccharide acarbose inhibits pancreatic islet glucan-1,4-alpha-glucosidase activity in parallel with a suppressive action on glucose-induced insulin release.

Salehi A; Panagiotidis G; Borg LA; Lundquist I
Article: BRITISH JOURNAL OF PHARMACOLOGY. 1995;114(2):289-296

Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.

Panagiotidis G; Akesson B; Rydell EL; Lundquist I
Journal article: METABOLISM-CLINICAL AND EXPERIMENTAL. 1993;42(11):1398-1404

Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice.

Panagiotidis G; Lindström P; Stenström A; Lundquist I
Journal article: PANCREAS. 1993;8(3):368-374

Influence of beta 2-adrenoceptor stimulation and glucose on islet monoamine oxidase activity and insulin secretory response in the mouse.

Panagiotidis G; Stenström A; Lundquist I
Journal article: EUROPEAN JOURNAL OF PHARMACOLOGY. 1993;233(2-3):285-290

Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse.

Panagiotidis G; Stenström A; Lundquist I
Journal article: EUROPEAN JOURNAL OF PHARMACOLOGY. 1992;229(2-3):277-278

Inhibition of islet nitric oxide synthase increases arginine-induced insulin release.

Panagiotidis G; Alm P; Lundquist I
Journal article: DIABETES RESEARCH AND CLINICAL PRACTICE. 1992;18(3):167-171

Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse.

Panagiotidis G; Salehi AA; Westermark P; Lundquist I
Journal article: PANCREAS. 1992;7(3):352-357

The relationship of islet amyloglucosidase activity and glucose-induced insulin secretion.

Lundquist I; Panagiotidis G
Journal article: PANCREAS. 1991;6(5):522-527

Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse.

Lundquist I; Panagiotidis G; Stenström A
Journal article: PHARMACOLOGY. 1991;43(3):163-168

Effect of the lysosomotropic drug suramin on islet lysosomal enzyme activities and the insulin-secretory response induced by various secretagogues.

Panagiotidis G; Salehi AA; Lundquist I
Journal article: DIABETES RES. 1989;11(2):81-84

Monoamine oxidase (MAO) in pancreatic islets of the mouse: some characteristics and the effect of chemical sympathectomy.

Stenström A; Panagiotidis G; Lundquist I
Visa fler

Alla övriga publikationer

Other: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2020;108(6):1127-1128

Tribute to Folke Sjöqvist, a Pioneer in Clinical Pharmacology.

Dahl M-L; Bergman U; Bertilsson L; Eliasson E; Gustafsson LL; Panagiotidis G; Rane A
Conference publication: CLINICAL TOXICOLOGY. 2017;55(5):389-390

Potential pharmacobezoar formation of extended-release tablets and their dissolution: an in vitro study

Hoegberg LCG; Refsgaard F; Pedersen SH; Personne M; Ullah S; Panagiotidis G; Annas A
Conference publication: CLINICAL TOXICOLOGY. 2017;55(5):387

Disintegration and possible bezoar formation of large sized extended release tablets: an in vitro study

Annas A; Personne M; Pedersen SH; Refsgaard F; Panagiotidis G; Ullah S; Hoegberg LCG
Conference publication: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2016;99:S81

IN VIVO DIGOXIN KINETICS IN TWO DIFFERENT MDR1 GENOTYPES.

Sparve E; Akillu E; Bertilsson L; Panagiotidis G
Review: CLINICAL NEUROPHARMACOLOGY. 2012;35(3):111-117

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers.

Nyholm D; Lewander T; Gomes-Trolin C; Bäckström T; Panagiotidis G; Ehrnebo M; Nyström C; Aquilonius S-M
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2009;29:S575-S576

A comparison of grey matter density in restless legs syndrome patients and matched controls, using FSL-VBM

Comley R; Cervenka S; Palhagen S; Panagiotidis G; Matthews J; Lai R; Halldin C; Farde L; Nichols T; Whitcher B
Book chapter: PHARMACOGENOMICS, SECOND EDITION: DRUGS AND THE PHARMACEUTICAL SCIENCES. 2005;p. 51-69

Pharmacogenetics of Drug Metabolism

Bertilsson L; Panagiotidis G
Conference publication: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2005;238:S47

Increased dopamine D2-receptor availability in patients with Restless Legs Syndrome as measured with Positron Emission Tomography

Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L

Anställningar

Universitetslektor/Överläkare, Laboratoriemedicin, Karolinska Institutet, 2004-

Examina och utbildning

Docent, Klinisk farmakologi, Karolinska Institutet, 2008

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI